IP Library › Assignment 053225/0444
Patent Assignment
Reel/Frame 053225/0444

Merger

Recorded: 2020-07-16 Pages: 9
Assignor
TOLERO PHARMACEUTICALS, INC.
Executed: 2020-07-01
Assignee
SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
640 MEMORIAL DRIVE, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties (12)
Heterocyclic Protein Kinase Inhibitors
PKM2 Modulators and Methods for Their Use
JAK2 and ALK2 Inhibitors and Methods for Their Use
Alvocidib Prodrugs Having Increased Bioavailability
Imidazo[1,2-B]Pyridazine and Pyrazolo[1,5-a]Pyrimidine Derivatives and Their Use as Protein Kinase Inhibitors
Patent: 8,710,057 →
Application: 13/188,195 →
Publication: US 2011/0281863
Predicting Response to Alvocidib by Mitochondrial Profiling
Application: 15/874,755 →
IMIDAZO[1,2-b]PYRIDAZINE AND PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
Application: 60/864,566 →
IMIDAZO[1,2-b]PYRIDAZINE AND PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
Application: 60/892,523 →
IMIDAZO[1,2-b]PYRIDAZINE AND PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
Application: 60/957,988 →
[1,2,4]Triazolo[4,3-A]Pyridine Derivatives and Their Use as Protein Kinase Inhibitors
Application: 61/510,207 →
Imidazo[1,2-B]Pyridazine and Pyrazolo[1,5-a]Pyrimidine Derivatives and Their Use as Protein Kinase Inhibitors
Application: 61/608,028 →
Imidazo[1,2-B]Pyridazine and Pyrazolo[1,5-a]Pyrimidine Derivatives and Their Use as Protein Kinase Inhibitors
Application: 61/632,826 →
Related Assignments (23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 2, 2007
From: BEARSS, DAVID J.; VANKAYALAPATI, HARIPRASAD; LIU, XIAO-HUI
To: SUPERGEN, INC.
Reel/Frame 018954/0792 →
Assignment of Assignor's Interest Mar 30, 2007
From: BEARSS, DAVID J.; LIU, XIAO-HUI; VANKAYALAPATI, HARIPRASAD
To: SUPERGEN, INC.
Reel/Frame 019095/0209 →
Assignment of Assignor's Interest Nov 8, 2007
From: BEARSS, DAVID J.; LIU, XIAO-HUI; VANKAYALAPATI, HARIPRASAD
To: SUPERGEN, INC.
Reel/Frame 020085/0921 →
Assignment of Assignor's Interest Nov 15, 2011
From: XU, YONG; YUAN, YI; BRENNING, BENJAMIN G.; HO, KOC-KAN
To: SUPERGEN, INC.
Reel/Frame 027230/0779 →
Merger/Name Change Feb 22, 2012
From: SUPERGEN, INC.
To: ASTEX PHARMACEUTICALS. INC.
Reel/Frame 027747/0334 →
Assignment of Assignor's Interest Jul 26, 2012
From: ASTEX PHARMACEUTICALS, INC.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 028650/0717 →
Security Interest Nov 17, 2016
From: TOLERO PHARMACEUTICALS, INC.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 040362/0884 →
Merger Jul 10, 2020
From: SUPERGEN, INC.
To: ASTEX PHARMACEUTICALS, INC.
Reel/Frame 053174/0873 →
Assignment of Assignor's Interest Jul 10, 2020
From: BEARSS, DAVID J.; LIU, XIAO-HUI; VANKAYALAPATI, HARIPRASAD; XU, YONG
To: SUPERGEN, INC.
Reel/Frame 053175/0064 →
Assignment of Assignor's Interest Jul 10, 2020
From: HO, KOC-KAN; XU, YONG; SAUNDERS, MICHAEL DAVID; LIU, XIAOHUI
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 053185/0028 →
Assignment of Assignor's Interest Jul 10, 2020
From: WARNER, STEVEN L.; BEARSS, DAVID J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 053173/0487 →
Assignment of Assignor's Interest Jul 10, 2020
From: MOLLARD, ALEXIS; WARNER, STEVEN L.; FLYNN, GARY A.; VANKAYALAPATI, HARIPRASAD
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 053173/0591 →
Assignment of Assignor's Interest Jul 10, 2020
From: SIDDIQUI-JAIN, ADAM; BEARSS, DAVID J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 053173/0756 →
Assignment of Assignor's Interest Jul 10, 2020
From: HO, KOC-KAN
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 053174/0270 →
Assignment of Assignor's Interest Jul 10, 2020
From: XU, YONG; BRENNING, BENJAMIN GARY; KULTGEN, STEVEN G.; LIU, XIAOHUI
To: ASTEX PHARMACEUTICALS, INC.
Reel/Frame 053174/0449 →
Assignment of Assignor's Interest Jul 10, 2020
From: ASTEX PHARAMCEUTICALS, INC.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 053174/0561 →
Assignment of Assignor's Interest Jul 16, 2020
From: XU, YONG; BRENNING, BENJAMIN G.; KULTGEN, STEVEN G.; LIU, XIAOHUI
To: ASTEX PHARMACEUTICALS, INC.
Reel/Frame 053224/0007 →
Change of Name Jul 16, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053225/0690 →
Assignment of Assignor's Interest Jul 16, 2020
From: XU, YONG; BRENNING, BENJAMIN G.; KULTGEN, STEVEN G.; LIU, XIAOHUI
To: ASTEX PHARMACEUTICALS, INC.
Reel/Frame 053224/0075 →
Corrective Assignment to Correct the Receiving Party Name Previously Recorded on Reel 053225 Frame 0444. Assignor(S) Hereby Confirms the Merger. Jul 17, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053242/0090 →
Change of Name Apr 25, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059787/0758 →
Change of Name Apr 27, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059810/0102 →
Merger Sep 18, 2024
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 068618/0375 →